Longer Gap Between Chemo, Esophageal Resection Tied to Better Response Longer Gap Between Chemo, Esophageal Resection Tied to Better Response
In patients with esophageal cancer, increasing the interval between neoadjuvant chemoradiotherapy and resection beyond six weeks is associated with better odds of pathologic complete response, according to a new study.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Esophagus Cancer | Health | Hematology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Surgery